Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 350,386 shares of BLFS, which is worth approximately $8.43 Million. The most recent transaction as insider was on Apr 19, 2023, when has been sold 10,000 shares (Common Stock) at a price of $19.47 per share, resulting in proceeds of $194,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 350K

0.29% 3M change

23.41% 12M change

Total Value Held $8.43 Million

Aby J. Mathew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 19 2023	SELL Open market or private sale	$194,700 $19.47 p/Share	10,000 Reduced 3.59%	268,352 Common Stock
Apr 19 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.47%	278,352 Common Stock
Apr 06 2023	SELL Open market or private sale	$41,922 $20.03 p/Share	2,093 Reduced 0.77%	268,352 Common Stock
Mar 29 2023	SELL Open market or private sale	$15,279 $20.62 p/Share	741 Reduced 0.27%	270,445 Common Stock
Mar 23 2023	SELL Open market or private sale	$217,900 $21.79 p/Share	10,000 Reduced 3.56%	271,186 Common Stock
Mar 23 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.43%	281,186 Common Stock
Mar 22 2023	SELL Open market or private sale	$214,400 $21.44 p/Share	10,000 Reduced 3.56%	271,186 Common Stock

Mar 22 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.43%	281,186 Common Stock
Mar 07 2023	SELL Open market or private sale	$9,524 $22.95 p/Share	415 Reduced 0.15%	271,186 Common Stock
Mar 01 2023	SELL Open market or private sale	$47,456 $22.75 p/Share	2,086 Reduced 0.76%	271,601 Common Stock
Feb 09 2023	SELL Open market or private sale	$1,918 $24.6 p/Share	78 Reduced 0.03%	273,687 Common Stock
Feb 02 2023	SELL Open market or private sale	$244,300 $24.43 p/Share	10,000 Reduced 3.52%	273,765 Common Stock
Feb 02 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.42%	282,765 Common Stock
Feb 01 2023	SELL Open market or private sale	$228,700 $22.87 p/Share	10,000 Reduced 3.52%	273,765 Common Stock
Feb 01 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.4%	283,765 Common Stock
Jan 04 2023	SELL Open market or private sale	$181,000 $18.1 p/Share	10,000 Reduced 3.8%	252,826 Common Stock
Jan 04 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.67%	262,326 Common Stock
Jan 03 2023	SELL Open market or private sale	$182,600 $18.26 p/Share	10,000 Reduced 3.8%	252,826 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	20,939 Added 7.11%	273,765 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.8%	253,326 Common Stock
Dec 28 2022	SELL Open market or private sale	$12,032 $16.9 p/Share	712 Reduced 0.28%	252,826 Common Stock
Nov 29 2022	SELL Open market or private sale	$8,689 $19.93 p/Share	436 Reduced 0.17%	253,538 Common Stock
Nov 10 2022	SELL Open market or private sale	$2,478 $23.16 p/Share	107 Reduced 0.04%	253,974 Common Stock
Sep 29 2022	SELL Open market or private sale	$15,124 $23.02 p/Share	657 Reduced 0.26%	254,081 Common Stock
Aug 31 2022	SELL Open market or private sale	$9,962 $23.44 p/Share	425 Reduced 0.17%	254,738 Common Stock

AJM

Aby J. Mathew

EVP & Chief Scientific Officer

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account